SCHEMBL8808649

SCHEMBL8808649

COc1ccccc1-c1ccc([N+](=O)[O-])c(F)c1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
TDP1 Q9NUW8 4/20 0.49
EIF4E P06730 1/20 0.45
L3MBTL1 Q9Y468 3/20 0.44
MAPT P10636 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
S1PR1 P21453 1/20 0.41
HTT P42858 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8876243 0.85 ALDH1A1 (0.50) ALDH1A1TDP1EIF4EL3MBTL1MAPT
SCHEMBL6650948 0.84 ALDH1A1 (0.49) ALDH1A1TDP1EIF4EL3MBTL1MAPT
SCHEMBL24319617 0.83 TDP1 (0.50) ALDH1A1TDP1L3MBTL1MAPTSMN1; SMN2
SCHEMBL6652911 0.79 KMT2A (0.42) ALDH1A1TDP1EIF4EL3MBTL1MAPT
SCHEMBL6425266 0.75 ALDH1A1 (0.72) ALDH1A1TDP1EIF4EL3MBTL1MAPT
SCHEMBL8403658 0.75 EIF4E (0.53) ALDH1A1TDP1EIF4EL3MBTL1MAPT
SCHEMBL3600729 0.74 CA12 (0.65) ALDH1A1TDP1L3MBTL1MAPTSMN1; SMN2
SCHEMBL20920009 0.73 TDP1 (0.49) ALDH1A1TDP1L3MBTL1MAPTSMN1; SMN2
SCHEMBL24319898 0.73 TDP1 (0.49) ALDH1A1TDP1L3MBTL1MAPTKDM4E
SCHEMBL8381593 0.73 CA12 (0.74) ALDH1A1TDP1SMN1; SMN2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0800519-A1 STEROID RECEPTOR MODULATOR COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS, INC. (US) 1997-10-15 EP disclosed
WO-1996019458-A2 STEROID RECEPTOR MODULATOR COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS INCORPORATED (US) 1996-06-27 WO disclosed